Logo for Atara Biotherapeutics Inc

Atara Biotherapeutics Investor Relations Material

Latest events

Logo for Atara Biotherapeutics Inc

AGM 2024

Atara Biotherapeutics
Logo for Atara Biotherapeutics

AGM 2024

10 Jun, 2024
Logo for Atara Biotherapeutics

Q1 2024

9 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Atara Biotherapeutics Inc

Access all reports
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company develops its product candidates which is designed to harness the body's innate immune system to treat hematologic cancers including multiple myeloma. The company's research focuses on adoptive immunotherapy methodologies and next-generation products that utilize novel chimeric antigen receptors (CAR) technology to target specific antigens associated with a specific disease or condition.